BIOMAT Database Logo BIOMAT Database Logo

Atrial flutter in patients treated for atrial fibrillation with propafenone. 1990

C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
University Hospital (UBC Site), University of British Columbia, Vancouver, Canada.

UI MeSH Term Description Entries
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D001282 Atrial Flutter Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES). Auricular Flutter,Atrial Flutters,Auricular Flutters,Flutter, Atrial,Flutter, Auricular,Flutters, Atrial,Flutters, Auricular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
[Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
November 2008, Kardiologia polska,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
September 1999, Journal of cardiovascular electrophysiology,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Proarrhythmia in patients treated for atrial fibrillation or flutter.
July 1992, Annals of internal medicine,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
[A case of recent atrial flutter treated with intravenous propafenone].
January 1989, Minerva cardioangiologica,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
August 2004, Journal of the American College of Cardiology,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
January 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter.
October 1988, Journal of the American College of Cardiology,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Intravenous propafenone for suppression of symptomatic atrial fibrillation and atrial flutter in a first aid hospital.
January 1992, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
February 1997, The American journal of cardiology,
C J Murdock, and A E Kyles, and J A Yeung-Lai-Wah, and A Qi, and S Vorderbrugge, and C R Kerr
[Paroxysmal atrial fibrillation, atrial flutter, and atrial flutter-fibrillation].
January 1996, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!